Exact Mass: 308.1749

Exact Mass Matches: 308.1749

Found 80 metabolites which its exact mass value is equals to given mass value 308.1749, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

bestatin

(2R)-2-[[(2S,3R)-3-Amino-2-hydroxy-4-phenyl-butanoyl]amino]-4-methyl-pentanoic acid

C16H24N2O4 (308.1736)


KEIO_ID B018; [MS2] KO009090 KEIO_ID B018 Bestatin is a natural, broad-spectrum, and competitive CD13 (Aminopeptidase N)/APN and leukotriene A4 hydrolase inhibitor. Bestatin has anticancer effects[1][2].

   

2-(3,7-Dimethyl-2,6-octadienyl)-3-methyl-1,4-naphthoquinone

2-(3,7-Dimethyl-2,6-octadienyl)-3-methyl-1,4-naphthoquinone

C21H24O2 (308.1776)


   

2-[(2E)-3,7-dimethylocta-2,6-dienyl]-5-methylnaphthalene-1,4-dione

2-[(2E)-3,7-dimethylocta-2,6-dienyl]-5-methylnaphthalene-1,4-dione

C21H24O2 (308.1776)


   

(R)-1-O-b-D-glucopyranosyl-1,3-octanediol

2-(hydroxymethyl)-6-[(3-hydroxyoctyl)oxy]oxane-3,4,5-triol

C14H28O7 (308.1835)


(R)-1-O-b-D-glucopyranosyl-1,3-octanediol is found in pomes. (R)-1-O-b-D-glucopyranosyl-1,3-octanediol is a constituent of apples Constituent of apples. (R)-1-O-b-D-glucopyranosyl-1,3-octanediol is found in pomes.

   

Gestrinone

(10S,11S,14R,15S)-15-ethyl-14-ethynyl-14-hydroxytetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadeca-1,6,16-trien-5-one

C21H24O2 (308.1776)


Gestrinone was developed in the early 1970s and was tested clinically as a weekly oral contraceptive in European and North American countries. ]. Without significant advantages over other oral contraceptives and with its high price, gestrinone was no longer used after the Stage II clinical trial. However, from 1982 aroused widespread interest due to substantial therapeutic effects in treating endometriosis. Under different endocrine conditions, gestrinone possesses estrogenic, progestational, androgenic, antiestrogenic and antiprogesterone actions. Starting from gestrinone, chemists can synthesize tetrahydrogestrinone (THG) in one reaction step. THG is a real designer steroid; designer steroids (chemically modified steroids) pose a threat to the integrity of the sport community. These compounds have recently been detected in urine specimens from athletes, resulting in temporary or permanent suspension from amateur and/or professional competition. (PMID: 15934041, 17707720) [HMDB] Gestrinone was developed in the early 1970s and was tested clinically as a weekly oral contraceptive in European and North American countries. ]. Without significant advantages over other oral contraceptives and with its high price, gestrinone was no longer used after the Stage II clinical trial. However, from 1982 aroused widespread interest due to substantial therapeutic effects in treating endometriosis. Under different endocrine conditions, gestrinone possesses estrogenic, progestational, androgenic, antiestrogenic and antiprogesterone actions. Starting from gestrinone, chemists can synthesize tetrahydrogestrinone (THG) in one reaction step. THG is a real designer steroid; designer steroids (chemically modified steroids) pose a threat to the integrity of the sport community. These compounds have recently been detected in urine specimens from athletes, resulting in temporary or permanent suspension from amateur and/or professional competition. (PMID: 15934041, 17707720). G - Genito urinary system and sex hormones > G03 - Sex hormones and modulators of the genital system > G03X - Other sex hormones and modulators of the genital system > G03XA - Antigonadotropins and similar agents D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones > D011372 - Progestins C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone D012102 - Reproductive Control Agents > D003270 - Contraceptive Agents

   

8-Hydroxycarteolol

5-[3-(tert-butylamino)-2-hydroxypropoxy]-3,4-dihydroquinoline-2,8-diol

C16H24N2O4 (308.1736)


8-Hydroxycarteolol is a metabolite of carteolol. Carteolol (trade names Cartrol, Ocupress, Teoptic, Arteolol, Arteoptic, Calte, Cartéabak, Carteol, Cartéol, Cartrol, Elebloc, Endak, Glauteolol, Mikelan, Poenglaucol, Singlauc) is a non-selective beta blocker used to treat glaucoma. (Wikipedia)

   

(2R)-2-[[(2S,3R)-3-Amino-2-hydroxy-4-phenyl-butanoyl]amino]-4-methyl-pentanoic acid

(2R)-2-[[(2S,3R)-3-Amino-2-hydroxy-4-phenyl-butanoyl]amino]-4-methyl-pentanoic acid

C16H24N2O4 (308.1736)


   

Baquiloprim

5-{[8-(dimethylamino)-7-methylquinolin-5-yl]methyl}pyrimidine-2,4-diamine

C17H20N6 (308.1749)


C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C277 - Antiprotozoal Agent

   

Diacetolol

RS-1-(4-acetamido-2-Acetylphenoxy)-2-hydroxy-3-isopropylaminopropane hydrochloride

C16H24N2O4 (308.1736)


   

n-octyl-beta-D-thioglucopyranoside

2-(hydroxymethyl)-6-(octylsulfanyl)oxane-3,4,5-triol

C14H28O5S (308.1657)


   

Ubenimex

(2S)-2-[[(2S,3R)-3-amino-2-hydroxy-4-phenyl-butanoyl]amino]-4-methyl-pentanoic acid

C16H24N2O4 (308.1736)


Ubenimex (also known as bestatin) is a competitive protease inhibitor. It is an inhibitor of aminopeptidase B, leukotriene A4 hydrolase, aminopeptidase N. It is being studied for use in the treatment of acute myelocytic leukemia. Ubenimex is a microbial metabolite and dipeptide with potential immunomodulatory and antitumor activities. Ubenimex competitively inhibits many aminopeptidases, including B, N and leucine aminopeptidases. Aminopeptidases has been implicated in the process of cell adhesion and invasion of tumor cells. Therefore, inhibiting aminopeptidases may partially attribute to the antitumor effect of ubenimex. This agent also activates T lymphocyte, macrophage and bone marrow stem cell as well as stimulates release of interleukin-1 and -2, thus further enhances its antitumor activity. D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D044966 - Anti-Retroviral Agents D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors C308 - Immunotherapeutic Agent > C2139 - Immunostimulant D000970 - Antineoplastic Agents D007155 - Immunologic Factors Bestatin is a natural, broad-spectrum, and competitive CD13 (Aminopeptidase N)/APN and leukotriene A4 hydrolase inhibitor. Bestatin has anticancer effects[1][2].

   
   

Diacetolol

Diacetolol

C16H24N2O4 (308.1736)


C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist

   

Baquiloprim

Baquiloprim

C17H20N6 (308.1749)


C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C277 - Antiprotozoal Agent CONFIDENCE standard compound; INTERNAL_ID 1178

   

Dehydrocannabifuran

Dehydrocannabifuran

C21H24O2 (308.1776)


   

3,5-dimethoxy-4-prenylstilbene

3,5-dimethoxy-4-prenylstilbene

C21H24O2 (308.1776)


   

sarcidumitol

sarcidumitol

C14H28O7 (308.1835)


   

(+)-(4aS,12bS)-4,4,12b-trimethyl-1,2,3,4,4a,5,6,12b-octahydrobenzo[a]anthracene-8,11-dione|(+)-cyclozonarone|Cyclozonarone

(+)-(4aS,12bS)-4,4,12b-trimethyl-1,2,3,4,4a,5,6,12b-octahydrobenzo[a]anthracene-8,11-dione|(+)-cyclozonarone|Cyclozonarone

C21H24O2 (308.1776)


   
   
   

Ubenimex (Bestatin)

Ubenimex (Bestatin)

C16H24N2O4 (308.1736)


   

(2R,3S,4S,5R,6R)-2-(hydroxymethyl)-6-(3-hydroxy-6-methylheptoxy)oxane-3,4,5-triol

NCGC00380218-01!(2R,3S,4S,5R,6R)-2-(hydroxymethyl)-6-(3-hydroxy-6-methylheptoxy)oxane-3,4,5-triol

C14H28O7 (308.1835)


   

(2R,3S,4S,5R,6R)-2-(hydroxymethyl)-6-(3-hydroxy-6-methylheptoxy)oxane-3,4,5-triol [IIN-based on: CCMSLIB00000845933]

NCGC00380218-01!(2R,3S,4S,5R,6R)-2-(hydroxymethyl)-6-(3-hydroxy-6-methylheptoxy)oxane-3,4,5-triol [IIN-based on: CCMSLIB00000845933]

C14H28O7 (308.1835)


   

(2R,3S,4S,5R,6R)-2-(hydroxymethyl)-6-(3-hydroxy-6-methylheptoxy)oxane-3,4,5-triol [IIN-based: Match]

NCGC00380218-01!(2R,3S,4S,5R,6R)-2-(hydroxymethyl)-6-(3-hydroxy-6-methylheptoxy)oxane-3,4,5-triol [IIN-based: Match]

C14H28O7 (308.1835)


   

8-Hydroxycarteolol

8-Hydroxycarteolol

C16H24N2O4 (308.1736)


   

Gestrinone

13-ethyl-17α-hydroxy-18,19-dinorpregna-4,9,11-trien-20-yn-3-one

C21H24O2 (308.1776)


G - Genito urinary system and sex hormones > G03 - Sex hormones and modulators of the genital system > G03X - Other sex hormones and modulators of the genital system > G03XA - Antigonadotropins and similar agents D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones > D011372 - Progestins C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone D012102 - Reproductive Control Agents > D003270 - Contraceptive Agents

   

(R)-1-O-b-D-glucopyranosyl-1,3-octanediol

2-(hydroxymethyl)-6-[(3-hydroxyoctyl)oxy]oxane-3,4,5-triol

C14H28O7 (308.1835)


   

DESOXY-TETRAENE(5-ST)

DESOXY-TETRAENE(5-ST)

C21H24O2 (308.1776)


   

4-Boc-7,8-Dimethoxy-2,3,4,5-tetrahydro-1H-benzo[e][1,4]diazepine

4-Boc-7,8-Dimethoxy-2,3,4,5-tetrahydro-1H-benzo[e][1,4]diazepine

C16H24N2O4 (308.1736)


   

2-Methoxycarbonyl-1-phenylethylboronic acid pinacol ester

2-Methoxycarbonyl-1-phenylethylboronic acid pinacol ester

C16H25BO5 (308.1795)


   

boc-phe-n(och3)ch3

boc-phe-n(och3)ch3

C16H24N2O4 (308.1736)


   

11-MERCAPTOUNDECYLTRIMETHOXYSILANE

11-MERCAPTOUNDECYLTRIMETHOXYSILANE

C14H32O3SSi (308.1841)


   

1H-Pyrrolo[2,3-b]pyridin-5-ol, 4-fluoro-1-[tris(1-methylethyl)silyl]-

1H-Pyrrolo[2,3-b]pyridin-5-ol, 4-fluoro-1-[tris(1-methylethyl)silyl]-

C16H25FN2OSi (308.172)


   

Octyl thioglucoside

2-Hydroxymethyl-6-octylsulfanyl-tetrahydro-pyran-3,4,5-triol

C14H28O5S (308.1657)


D013501 - Surface-Active Agents > D003902 - Detergents

   

Bisphenol A diallyl ether

Bisphenol A diallyl ether

C21H24O2 (308.1776)


   

Diallyl bisphenol A

Diallyl bisphenol A

C21H24O2 (308.1776)


   

2-(9H-CARBAZOLYL)ETHYLBORONIC ACID DIETHANOLAMINE ESTER

2-(9H-CARBAZOLYL)ETHYLBORONIC ACID DIETHANOLAMINE ESTER

C18H21BN2O2 (308.1696)


   

methyl 3,3-dimethoxy-2-oxa-7,10-diaza-3-silatridecan-13-oate

methyl 3,3-dimethoxy-2-oxa-7,10-diaza-3-silatridecan-13-oate

C12H28N2O5Si (308.1767)


   

tert-butyl N-[1-(benzylamino)-3-methoxy-1-oxopropan-2-yl]carbamate

tert-butyl N-[1-(benzylamino)-3-methoxy-1-oxopropan-2-yl]carbamate

C16H24N2O4 (308.1736)


   

N,N-DI-TERT-BUTOXYCARBONYL-BENZENE-1,4-DIAMINE

N,N-DI-TERT-BUTOXYCARBONYL-BENZENE-1,4-DIAMINE

C16H24N2O4 (308.1736)


   

(S)-ETHYL 3-(4-AMINOPHENYL)-2-((TERT-BUTOXYCARBONYL)AMINO)PROPANOATE

(S)-ETHYL 3-(4-AMINOPHENYL)-2-((TERT-BUTOXYCARBONYL)AMINO)PROPANOATE

C16H24N2O4 (308.1736)


   

HIV-1 integrase inhibitor 8

HIV-1 integrase inhibitor 8

C21H24O2 (308.1776)


   

Benzeneacetic acid,2-[2-(dipropylamino)ethyl]-6-nitro-

Benzeneacetic acid,2-[2-(dipropylamino)ethyl]-6-nitro-

C16H24N2O4 (308.1736)


   

(R)-tert-Butyl 1-(benzylamino)-3-methoxy-1-oxopropan-2-ylcarbamate

(R)-tert-Butyl 1-(benzylamino)-3-methoxy-1-oxopropan-2-ylcarbamate

C16H24N2O4 (308.1736)


   

3-Fluoro-2-(4-morpholino)pyridine-4-boronic acid pinacol ester

3-Fluoro-2-(4-morpholino)pyridine-4-boronic acid pinacol ester

C15H22BFN2O3 (308.1707)


   

TERT-BUTYL 2-(1-(4-(ETHOXYCARBONYL)PHENYL)ETHYL)HYDRAZINECARBOXYLATE

TERT-BUTYL 2-(1-(4-(ETHOXYCARBONYL)PHENYL)ETHYL)HYDRAZINECARBOXYLATE

C16H24N2O4 (308.1736)


   

Dimethisoquin hydrochloride

Dimethisoquin hydrochloride

C17H25ClN2O (308.1655)


D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D000777 - Anesthetics D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents C78272 - Agent Affecting Nervous System > C245 - Anesthetic Agent

   

Octyl 1-thiohexopyranoside

Octyl 1-thiohexopyranoside

C14H28O5S (308.1657)


   

2-[(3-Azaniumyl-2-hydroxy-4-phenylbutanoyl)amino]-4-methylpentanoate

2-[(3-Azaniumyl-2-hydroxy-4-phenylbutanoyl)amino]-4-methylpentanoate

C16H24N2O4 (308.1736)


   

1-[(3-chlorophenyl)methyl]-N,N-diethyl-3-piperidinecarboxamide

1-[(3-chlorophenyl)methyl]-N,N-diethyl-3-piperidinecarboxamide

C17H25ClN2O (308.1655)


   

N-(2,5-diethoxy-4-morpholin-4-ylphenyl)acetamide

N-(2,5-diethoxy-4-morpholin-4-ylphenyl)acetamide

C16H24N2O4 (308.1736)


   

N-[(2R,3R,6S)-6-[2-(cyclobutylamino)-2-oxoethyl]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-3-yl]cyclopropanecarboxamide

N-[(2R,3R,6S)-6-[2-(cyclobutylamino)-2-oxoethyl]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-3-yl]cyclopropanecarboxamide

C16H24N2O4 (308.1736)


   

N-[(2R,3S,6S)-6-[2-(cyclobutylamino)-2-oxoethyl]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-3-yl]cyclopropanecarboxamide

N-[(2R,3S,6S)-6-[2-(cyclobutylamino)-2-oxoethyl]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-3-yl]cyclopropanecarboxamide

C16H24N2O4 (308.1736)


   

N-[(2S,3S,6S)-6-[2-(cyclobutylamino)-2-oxoethyl]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-3-yl]cyclopropanecarboxamide

N-[(2S,3S,6S)-6-[2-(cyclobutylamino)-2-oxoethyl]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-3-yl]cyclopropanecarboxamide

C16H24N2O4 (308.1736)


   

N-[(2S,3R,6R)-6-[2-(cyclobutylamino)-2-oxoethyl]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-3-yl]cyclopropanecarboxamide

N-[(2S,3R,6R)-6-[2-(cyclobutylamino)-2-oxoethyl]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-3-yl]cyclopropanecarboxamide

C16H24N2O4 (308.1736)


   

N-[(2S,3R,6S)-6-[2-(cyclobutylamino)-2-oxoethyl]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-3-yl]cyclopropanecarboxamide

N-[(2S,3R,6S)-6-[2-(cyclobutylamino)-2-oxoethyl]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-3-yl]cyclopropanecarboxamide

C16H24N2O4 (308.1736)


   

N-[(2R,3R,6R)-6-[2-(cyclobutylamino)-2-oxoethyl]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-3-yl]cyclopropanecarboxamide

N-[(2R,3R,6R)-6-[2-(cyclobutylamino)-2-oxoethyl]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-3-yl]cyclopropanecarboxamide

C16H24N2O4 (308.1736)


   

N-[(2R,3S,6R)-6-[2-(cyclobutylamino)-2-oxoethyl]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-3-yl]cyclopropanecarboxamide

N-[(2R,3S,6R)-6-[2-(cyclobutylamino)-2-oxoethyl]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-3-yl]cyclopropanecarboxamide

C16H24N2O4 (308.1736)


   

N-[(2S,3S,6R)-6-[2-(cyclobutylamino)-2-oxoethyl]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-3-yl]cyclopropanecarboxamide

N-[(2S,3S,6R)-6-[2-(cyclobutylamino)-2-oxoethyl]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-3-yl]cyclopropanecarboxamide

C16H24N2O4 (308.1736)


   

(8S,13S,14R,17R)-13-ethyl-17-ethynyl-17-hydroxy-1,2,6,7,8,14,15,16-octahydrocyclopenta[a]phenanthren-3-one

(8S,13S,14R,17R)-13-ethyl-17-ethynyl-17-hydroxy-1,2,6,7,8,14,15,16-octahydrocyclopenta[a]phenanthren-3-one

C21H24O2 (308.1776)


   

13-Ethyl-17-ethynyl-17-hydroxy-1,2,6,7,8,14,15,16-octahydrocyclopenta[a]phenanthren-3-one

13-Ethyl-17-ethynyl-17-hydroxy-1,2,6,7,8,14,15,16-octahydrocyclopenta[a]phenanthren-3-one

C21H24O2 (308.1776)


   

2-[4-(2-Trimethylsilyloxy-2-methylpropyl)phenyl]propanoic acid methyl ester

2-[4-(2-Trimethylsilyloxy-2-methylpropyl)phenyl]propanoic acid methyl ester

C17H28O3Si (308.1808)


   

(2R,3S,4S,5R,6R)-2-(hydroxymethyl)-6-(3-hydroxy-6-methylheptoxy)oxane-3,4,5-triol

(2R,3S,4S,5R,6R)-2-(hydroxymethyl)-6-(3-hydroxy-6-methylheptoxy)oxane-3,4,5-triol

C14H28O7 (308.1835)


   

(2R)-2-[[(2S,3R)-3-Amino-2-hydroxy-4-phenyl-butanoyl]amino]-4-methyl-pentanoic acid

(2R)-2-[[(2S,3R)-3-Amino-2-hydroxy-4-phenyl-butanoyl]amino]-4-methyl-pentanoic acid

C16H24N2O4 (308.1736)


Bestatin is a natural, broad-spectrum, and competitive CD13 (Aminopeptidase N)/APN and leukotriene A4 hydrolase inhibitor. Bestatin has anticancer effects[1][2].

   

[(2S,3R)-3-Amino-2-hydroxy-4-phenylbutyryl]-L-leucine

[(2S,3R)-3-Amino-2-hydroxy-4-phenylbutyryl]-L-leucine

C16H24N2O4 (308.1736)


   

Menaquinone

Menaquinone

C21H24O2 (308.1776)


   
   

(4as,12bs)-4,4,12b-trimethyl-1,2,3,4a,5,6-hexahydrotetraphene-8,11-dione

(4as,12bs)-4,4,12b-trimethyl-1,2,3,4a,5,6-hexahydrotetraphene-8,11-dione

C21H24O2 (308.1776)


   

(6e)-1,7-diphenylhept-6-en-3-yl acetate

(6e)-1,7-diphenylhept-6-en-3-yl acetate

C21H24O2 (308.1776)


   

4,4,12b-trimethyl-1,2,3,4a,5,6-hexahydrotetraphene-8,11-dione

4,4,12b-trimethyl-1,2,3,4a,5,6-hexahydrotetraphene-8,11-dione

C21H24O2 (308.1776)


   

(2r,3r,4s,5s,6r)-2-{[(3r)-3-ethyl-4-hydroxy-4-methylpentyl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2r,3r,4s,5s,6r)-2-{[(3r)-3-ethyl-4-hydroxy-4-methylpentyl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C14H28O7 (308.1835)


   

10-methyl-5-pentyl-13-(prop-1-en-2-yl)-8-oxatricyclo[7.4.0.0²,⁷]trideca-1(9),2(7),3,5,10,12-hexaen-3-ol

10-methyl-5-pentyl-13-(prop-1-en-2-yl)-8-oxatricyclo[7.4.0.0²,⁷]trideca-1(9),2(7),3,5,10,12-hexaen-3-ol

C21H24O2 (308.1776)


   

1,3-dimethoxy-2-(3-methylbut-2-en-1-yl)-5-[(1e)-2-phenylethenyl]benzene

1,3-dimethoxy-2-(3-methylbut-2-en-1-yl)-5-[(1e)-2-phenylethenyl]benzene

C21H24O2 (308.1776)


   

1,3-dimethoxy-2-(3-methylbut-2-en-1-yl)-5-(2-phenylethenyl)benzene

1,3-dimethoxy-2-(3-methylbut-2-en-1-yl)-5-(2-phenylethenyl)benzene

C21H24O2 (308.1776)


   

(2s)-2-{[(2s,3r)-3-amino-1,2-dihydroxy-4-phenylbutylidene]amino}-4-methylpentanoic acid

(2s)-2-{[(2s,3r)-3-amino-1,2-dihydroxy-4-phenylbutylidene]amino}-4-methylpentanoic acid

C16H24N2O4 (308.1736)


   

(2r,3s,4s,5r,6r)-2-(hydroxymethyl)-6-{[(3r)-3-hydroxyoctyl]oxy}oxane-3,4,5-triol

(2r,3s,4s,5r,6r)-2-(hydroxymethyl)-6-{[(3r)-3-hydroxyoctyl]oxy}oxane-3,4,5-triol

C14H28O7 (308.1835)


   

2-[(3-ethyl-4-hydroxy-4-methylpentyl)oxy]-6-(hydroxymethyl)oxane-3,4,5-triol

2-[(3-ethyl-4-hydroxy-4-methylpentyl)oxy]-6-(hydroxymethyl)oxane-3,4,5-triol

C14H28O7 (308.1835)


   

(4ar,12br)-4,4,12b-trimethyl-1,2,3,4a,5,6-hexahydrotetraphene-8,11-dione

(4ar,12br)-4,4,12b-trimethyl-1,2,3,4a,5,6-hexahydrotetraphene-8,11-dione

C21H24O2 (308.1776)


   

2-[(3-amino-1,2-dihydroxy-4-phenylbutylidene)amino]-4-methylpentanoic acid

2-[(3-amino-1,2-dihydroxy-4-phenylbutylidene)amino]-4-methylpentanoic acid

C16H24N2O4 (308.1736)